(Press-News.org) Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomised-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Professor Natasha Smallwood from Monash University, Melbourne, Australia.
Professor Smallwood told the Congress: “Chronic breathlessness is a common and highly distressing symptom for people with chronic obstructive pulmonary disease and interstitial lung disease. Yet there is a lack of safe, effective, and acceptable treatment options for managing this symptom.
“Group singing is increasingly used to manage symptoms and improve quality of life for people with neurological, mental health, and respiratory conditions, but we need more evidence to prove that this is beneficial, especially for people with interstitial lung disease.”
Interstitial lung disease (ILD) is a general term for a large group of conditions that cause progressive scarring and inflammation of the lung tissue affecting hundreds of thousands of people around world. Chronic obstructive pulmonary disease (COPD) is a serious lung condition affecting around 400 million people worldwide.
The SINFONIA study saw patients take part in a 90-minute online group singing session delivered once a week for 12 weeks over Zoom. The content of the SINFONIA sessions was developed and delivered by a registered music therapist and included dedicated time for warmups, breathing exercises, song singing, and social check ins to foster group connection.
The programme was delivered online to make it as easy as possible to take part, and patients were loaned iPads and given free data plans to help reduce barriers to participation. The group sang songs such as ‘Can’t Help Falling In Love’, ‘Let It Be’, and ‘Pack Up Your Troubles’.
Of the 101 participants, 50 were allocated to the singing sessions and 51 to a group who were given usual care (for example smoking cessation, respiratory vaccines, inhaler therapy, self-management education, and anti-fibrotic medications).
Sixty-four of the patients had chronic obstructive pulmonary disease (COPD), and 37 had interstitial lung disease (ILD).
Patients completed a questionnaire called the SF-36, which records their quality of life across eight sub domains (including pain, social functional, general health and fatigue). These domains are rated from 0 (worst quality of life) to 100 (best quality of life) and then averaged to give a total score.
SF-36 was 7.4 points higher in the singing group compared to the control group.
Professor Smallwood explained: “Compared to usual care, taking part in the SINFONIA singing programme led to improved quality of life for people with chronic obstructive pulmonary disease or interstitial lung disease with chronic breathlessness. These effects were most pronounced amongst people who attended at least 8 of the 12 sessions.
“We saw the greatest improvements in the domains that measured limitations due to physical health or emotional problems,” she adds.
There was also some evidence to suggest that women, people with anxiety or depression, and those who have not previously completed pulmonary rehabilitation experienced the greatest improvements in quality of life as a result of taking part in the online group singing programme.
“The way in which group singing improves quality of life remains unclear and may vary for different participants,” Professor Smallwood added. “But it could be due to better control of breathing, social connection, or mood improvements.”
Dr Apostolos Bossios, Head of the European Respiratory Society’s expert group on airway diseases, asthma, COPD and chronic cough, based at the at Karolinska Institutet, Sweden, who was not involved in the research said: “People with COPD and ILD suffer with long-term breathing difficulties, and this can severely restrict their day to day lives. These conditions cannot be cured, so we need better strategies to help people live happier, healthier lives.
“The world-first SINFONIA study adds to a growing body of evidence that supports using non-medication-based approaches for managing challenging conditions.
“By better understanding how group singing can be incorporated in existing healthcare services, we will be able to make a difference in the lives of patients with lung disease such as COPD and ILD.”
END
Specialised singing programmes can improve the symptoms and quality of life of people with lung disease
2025-09-28
ELSE PRESS RELEASES FROM THIS DATE:
Children with asthma who use at-home monitoring are half as likely to need hospital care
2025-09-28
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1]. Remote monitoring also helped keep children’s symptoms under control.
At-home monitoring involved children and their families using an app approximately once a month to answer questions ...
Combination inhaler reduces asthma attacks in children by almost half
2025-09-28
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.
The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – ...
Low-cost drug shows promise for patients with life threating respiratory infections
2025-09-28
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London.
The study analysed data from almost 500 patients hospitalised with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care.
Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, ...
Emergency medicine workers report job satisfaction, though burnout and staff retention remain major problems
2025-09-27
Vienna, Austria: One of the largest international surveys into job satisfaction among emergency department workers has revealed that while the majority found their work satisfying and rewarding, there are still many areas where improvements are needed, according to research presented at the European Emergency Medicine Congress today (Sunday) [1]. The paper, “Global Job Satisfaction Among Emergency Medicine Professionals: Results from the 2025 Emergency Medicine Day Survey”, is published today in the European Journal ...
Eating fruit may reduce the effects of air pollution on lung function
2025-09-27
Eating fruit may reduce the effects of air pollution on lung function
Eating fruit may reduce the effects of air pollution on lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Pimpika Kaewsri, a PhD student from the Centre for Environmental Health and Sustainability at the University of Leicester, UK.
She explains: “Over 90% of the global population is exposed to air pollution levels that exceed WHO guidelines, and ample ...
Pulp mill waste becomes green solution to remove toxic dyes
2025-09-27
Dyes like Congo red and methyl orange create brightly hued shirts, sweaters and dresses. But these commonly used azo dyes can be toxic, carcinogenic and are hard to remove from wastewater.
David Chem, a University of Arkansas chemical engineering Ph.D. candidate, developed an environmentally friendly solution to remove these dyes using a common byproduct of the pulp and paper industry.
Azo dyes are used in 60-70% of commercial textile production. The dyes dissolve easily in water and resist biodegradation, which makes them an environmental hazard. ...
Sustainable generative AI: UCLA develops novel light-based system
2025-09-26
Today’s popular chatbots and image generators have a severe downside for the environment.
These examples of generative artificial intelligence leave a substantial carbon footprint due to outsized energy demands. At the same time, the large amount of water used to cool the equipment behind generative AI depletes a finite resource that humans, other animals and plants need in order to survive. Additionally, running such models requires massive computational infrastructure, raising concerns about their long-term sustainability.
Now, researchers at the UCLA Samueli School of ...
University of Phoenix publishes new white paper on microservice using achieved skills to build confidence between students and employers
2025-09-26
University of Phoenix today announced the publication of a new white paper, “Leveraging Achieved Skills to Improve Confidence Between Students and Employers,” authored by Francisco Contreras and Brandon Edwards of the University’s careers product team. The paper outlines how a record of a learners’ achievements and attested skills can help students and employers speak a common language of skills, and help working adult learners see where they may qualify—and where they are close—before they apply.
“When learners can see verified, granular skills mapped from their coursework and experience—and employers can see the same—confidence ...
ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more
2025-09-26
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on targeted radioactive therapy for recurrent prostate cancer, new approaches to stereotactic body radiation for prostate and head and neck cancers, advances in MRI- and 5DCT-guided imaging for more precise treatments, and innovations in patient-focused cancer education.
At this year’s scientific meeting, Dr. Amar Kishan, executive vice chair of radiation oncology at UCLA and co-director of ...
University of Cincinnati Cancer Center members present radiation oncology research at national conference
2025-09-26
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) annual meeting Sept. 27 through Oct. 1 in San Francisco.
Study evaluates safety, efficacy of head and neck proton re-irradiation
Patients with head and neck malignancies face a high risk of disease recurrence and the development of secondary primary cancers. While surgery is the preferred treatment in these cases, it is not always feasible based on tumor location or prior treatments.
An additional course of proton radiation therapy called re-irradiation can be ...